BIORQ

Biora Therapeutics, Inc.

USD

Set alert

Price alert · BIORQ

All alert types
0.00 USD 0.00 0.00%
As of Oct 29, 2026
0.0001 Day range 0.0001
0.0001 52-week range 0.22
YTD
-99.95%
1 year
-99.95%
Open
0.0001
Prev close
0.0001
Mkt cap
452
Vol
3.03K
Avg vol
78
EPS
-0.01
P/E
0.00
More statistics
Low
0.0001
High
0.0001

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for BIORQ has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-109.16 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -1.7×
FY 2018: -6850×FY 2019: -10228×FY 2020: -3846×FY 2021: -2814×FY 2022: -1286×FY 2023: -1.7×
FY 2018 5y median -2814× FY 2023
P/S 53235×
FY 2018: 691×FY 2019: 1052×FY 2020: 996×FY 2021: 40289×FY 2022: 20605×FY 2023: 53235×
FY 2018 5y median 20605× FY 2023
P/B -2.1×
FY 2018: -2392×FY 2019: -1805×FY 2020: -692×FY 2021: -591×FY 2022: -61.4×FY 2023: -2.1×
FY 2018 5y median -591× FY 2023
P/FCF -4.4×
FY 2018: -1264×FY 2019: -1378×FY 2020: -434×FY 2021: -298×FY 2022: -96.4×FY 2023: -4.4×
FY 2018 5y median -298× FY 2023
EV/EBITDA -2.1×
FY 2018: -814×FY 2019: -1118×FY 2020: -698×FY 2021: -306×FY 2022: -171×FY 2023: -2.1×
FY 2018 5y median -306× FY 2023
EV/Sales 61289×
FY 2018: 691×FY 2019: 1052×FY 2020: 997×FY 2021: 40320×FY 2022: 20929×FY 2023: 61289×
FY 2018 5y median 20929× FY 2023
FCF Yield -22.8%
FY 2018: -0.1%FY 2019: -0.1%FY 2020: -0.2%FY 2021: -0.3%FY 2022: -1.0%FY 2023: -22.8%
FY 2018 5y median -0.3% FY 2023

Profitability

Gross Margin 100.0%
FY 2018: 28.1%FY 2019: 30.2%FY 2020: -25.7%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%
FY 2018 5y median 100.0% FY 2023
Operating Margin -1678575.0%
FY 2018: -89.3%FY 2019: -97.3%FY 2020: -144.8%FY 2021: -9449.6%FY 2022: -20256.1%FY 2023: -1678575.0%
FY 2018 5y median -9449.6% FY 2023
Net Margin -3102875.0%
FY 2018: -100.9%FY 2019: -102.8%FY 2020: -259.1%FY 2021: -14316.0%FY 2022: -12510.5%FY 2023: -3102875.0%
FY 2018 5y median -12510.5% FY 2023
ROE 122.4%
FY 2018: 349.2%FY 2019: 176.5%FY 2020: 179.9%FY 2021: 210.1%FY 2022: 37.3%FY 2023: 122.4%
FY 2018 5y median 176.5% FY 2023
ROIC 232.3%
FY 2018: -288.7%FY 2019: -5914.1%FY 2020: -96.6%FY 2021: -249.3%FY 2022: -196.9%FY 2023: 232.3%
FY 2018 5y median -196.9% FY 2023
ROA -397.6%
FY 2018: -110.9%FY 2019: -145.5%FY 2020: -124.7%FY 2021: -164.0%FY 2022: -71.3%FY 2023: -397.6%
FY 2018 5y median -145.5% FY 2023

Growth (YoY)

Revenue -98.7%
FY 2018: 0.0%FY 2019: 12.5%FY 2020: -48.4%FY 2021: -98.3%FY 2022: -75.5%FY 2023: -98.7%
FY 2018 FY 2023
Operating Income -8.7%
FY 2018: 0.0%FY 2019: -22.7%FY 2020: 23.2%FY 2021: -9.5%FY 2022: 47.6%FY 2023: -8.7%
FY 2018 FY 2023
EPS (diluted) -1129.7%
FY 2018: 0.0%FY 2019: 33.0%FY 2020: -7.6%FY 2021: 46.2%FY 2022: 86.2%FY 2023: -1129.7%
FY 2018 FY 2023
Free Cash Flow 25.5%
FY 2018: 0.0%FY 2019: -57.0%FY 2020: -55.4%FY 2021: 1.4%FY 2022: 61.3%FY 2023: 25.5%
FY 2018 FY 2023

Financial Health

Current Ratio 0.3×
FY 2018: 1.1×FY 2019: 0.7×FY 2020: 1.7×FY 2021: 1.6×FY 2022: 1.6×FY 2023: 0.3×
FY 2018 5y median 1.6× FY 2023
Quick Ratio 0.3×
FY 2018: 1.0×FY 2019: 0.6×FY 2020: 1.6×FY 2021: 1.6×FY 2022: 1.6×FY 2023: 0.3×
FY 2018 5y median 1.6× FY 2023
Debt / Equity -0.5×
FY 2018: -2.0×FY 2019: -0.9×FY 2020: -1.5×FY 2021: -1.5×FY 2022: -1.3×FY 2023: -0.5×
FY 2018 5y median -1.3× FY 2023
Net Debt / EBITDA -0.3×
FY 2018: -0.2×FY 2019: -0.3×FY 2020: -0.6×FY 2021: -0.2×FY 2022: -2.6×FY 2023: -0.3×
FY 2018 5y median -0.3× FY 2023
Interest Coverage -6.8×
FY 2018: -12.6×FY 2019: -15.2×FY 2020: -10.9×FY 2021: -9.3×FY 2022: -5.6×FY 2023: -6.8×
FY 2018 5y median -9.3× FY 2023

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2018 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: -3.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2018 5y median 0.0% FY 2023

Annual · latest fiscal year ends 2023-12-31